Connection

Azizul Haque to Humans

Back to Details
This is a "connection" page, showing publications Azizul Haque has written about Humans.
Azizul Haque
Connection Strength
0.610
Humans
  1. GILT Expression in Human Melanoma Cells Enhances Generation of Antigenic Peptides for HLA Class II-Mediated Immune Recognition. Int J Mol Sci. 2022 Jan 19; 23(3).
    View in: PubMed
    Score: 0.031
  2. Calpain activation and progression of inflammatory cycles in Parkinson's disease. Front Biosci (Landmark Ed). 2022 01 13; 27(1):20.
    View in: PubMed
    Score: 0.030
  3. Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy. J Autoimmun. 2022 02; 127:102792.
    View in: PubMed
    Score: 0.030
  4. Protective Effects of Estrogen via Nanoparticle Delivery to Attenuate Myelin Loss and Neuronal Death after Spinal Cord Injury. Neurochem Res. 2021 Nov; 46(11):2979-2990.
    View in: PubMed
    Score: 0.029
  5. Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis. Cytokine. 2020 11; 135:155219.
    View in: PubMed
    Score: 0.028
  6. Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease. Prog Mol Biol Transl Sci. 2019; 167:107-124.
    View in: PubMed
    Score: 0.026
  7. Endoplasmic reticulum stress, autophagic and apoptotic cell death, and immune activation by a natural triterpenoid in human prostate cancer cells. J Cell Biochem. 2019 04; 120(4):6264-6276.
    View in: PubMed
    Score: 0.024
  8. Autophagy-dependent crosstalk between GILT and PAX-3 influences radiation sensitivity of human melanoma cells. J Cell Biochem. 2018 02; 119(2):2212-2221.
    View in: PubMed
    Score: 0.023
  9. Neuron specific enolase: a promising therapeutic target in acute spinal cord injury. Metab Brain Dis. 2016 06; 31(3):487-95.
    View in: PubMed
    Score: 0.020
  10. RANK Ligand Modulation of Autophagy in Oral Squamous Cell Carcinoma Tumor Cells. J Cell Biochem. 2016 Jan; 117(1):118-25.
    View in: PubMed
    Score: 0.020
  11. Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors. J Immunol. 2015 Feb 15; 194(4):1434-45.
    View in: PubMed
    Score: 0.019
  12. Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid. J Cell Biochem. 2015 Jan; 116(1):102-14.
    View in: PubMed
    Score: 0.019
  13. Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition. Immunology. 2014 Jul; 142(3):492-505.
    View in: PubMed
    Score: 0.018
  14. A possible cross-talk between autophagy and apoptosis in generating an immune response in melanoma. Apoptosis. 2012 Oct; 17(10):1066-78.
    View in: PubMed
    Score: 0.016
  15. HLA class II defects in Burkitt lymphoma: bryostatin-1-induced 17 kDa protein restores CD4+ T-cell recognition. Clin Dev Immunol. 2011; 2011:780839.
    View in: PubMed
    Score: 0.015
  16. Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol. Leuk Lymphoma. 2012 Feb; 53(2):305-14.
    View in: PubMed
    Score: 0.015
  17. Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1. Cell Immunol. 2011; 271(2):392-400.
    View in: PubMed
    Score: 0.015
  18. Molecular alterations in glioblastoma: potential targets for immunotherapy. Prog Mol Biol Transl Sci. 2011; 98:187-234.
    View in: PubMed
    Score: 0.014
  19. HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition. Eur J Immunol. 2008 Jul; 38(7):1961-70.
    View in: PubMed
    Score: 0.012
  20. New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics. CNS Neurol Disord Drug Targets. 2008 Jun; 7(3):270-7.
    View in: PubMed
    Score: 0.012
  21. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Cancer Immunol Immunother. 2008 Oct; 57(10):1461-70.
    View in: PubMed
    Score: 0.012
  22. Defects in HLA class II antigen presentation in B-cell lymphomas. Leuk Lymphoma. 2008 Feb; 49(2):353-5.
    View in: PubMed
    Score: 0.012
  23. Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells. Cell Immunol. 2007 Sep; 249(1):20-9.
    View in: PubMed
    Score: 0.011
  24. HLA class II antigen presentation by prostate cancer cells. Prostate Cancer Prostatic Dis. 2008; 11(4):334-41.
    View in: PubMed
    Score: 0.011
  25. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Neurochem Res. 2007 Dec; 32(12):2203-9.
    View in: PubMed
    Score: 0.011
  26. Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells. Cancer Immunol Immunother. 2007 May; 56(5):615-25.
    View in: PubMed
    Score: 0.011
  27. New insights in antigen processing and epitope selection: development of novel immunotherapeutic strategies for cancer, autoimmunity and infectious diseases. J Biol Regul Homeost Agents. 2005 Jul-Dec; 19(3-4):93-104.
    View in: PubMed
    Score: 0.010
  28. Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson's Disease. Int J Mol Sci. 2022 Nov 10; 23(22).
    View in: PubMed
    Score: 0.008
  29. T helper 2-driven immune dysfunction in chronic arsenic-exposed individuals and its link to the features of allergic asthma. Toxicol Appl Pharmacol. 2021 06 01; 420:115532.
    View in: PubMed
    Score: 0.007
  30. The Pathophysiology of Osteoporosis after Spinal Cord Injury. Int J Mol Sci. 2021 Mar 17; 22(6).
    View in: PubMed
    Score: 0.007
  31. Cellular and molecular pathophysiology in the progression of Parkinson's disease. Metab Brain Dis. 2021 06; 36(5):815-827.
    View in: PubMed
    Score: 0.007
  32. Neuroinflammatory responses of microglia in central nervous system trauma. J Cereb Blood Flow Metab. 2020 12; 40(1_suppl):S25-S33.
    View in: PubMed
    Score: 0.007
  33. Association between chronic arsenic exposure and the characteristic features of asthma. Chemosphere. 2020 May; 246:125790.
    View in: PubMed
    Score: 0.007
  34. Cytokine/chemokine dysregulation in progressive MS patient is apparent and can be modulated by calpain inhibition. Metab Brain Dis. 2020 02; 35(2):255-261.
    View in: PubMed
    Score: 0.007
  35. RANKL triggers resistance to TRAIL-induced cell death in oral squamous cell carcinoma. J Cell Physiol. 2020 02; 235(2):1663-1673.
    View in: PubMed
    Score: 0.006
  36. Higher risk of hyperglycemia with greater susceptibility in females in chronic arsenic-exposed individuals in Bangladesh. Sci Total Environ. 2019 Jun 10; 668:1004-1012.
    View in: PubMed
    Score: 0.006
  37. Butyrylcholinesterase-a potential plasma biomarker in manganese-induced neurobehavioral changes. Environ Sci Pollut Res Int. 2019 Mar; 26(7):6378-6387.
    View in: PubMed
    Score: 0.006
  38. Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report. Neurochem Res. 2018 Dec; 43(12):2224-2231.
    View in: PubMed
    Score: 0.006
  39. Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res. 2018; 16(2):143-150.
    View in: PubMed
    Score: 0.006
  40. Alteration of CD39+Foxp3+ CD4 T cell and cytokine levels in EAE/MS following anti-CD52 treatment. J Neuroimmunol. 2017 02 15; 303:22-30.
    View in: PubMed
    Score: 0.005
  41. Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury. Rev Neurosci. 2016 04 01; 27(3):271-81.
    View in: PubMed
    Score: 0.005
  42. Cardiovascular risk profile and management of atrial fibrillation in India: Real world data from RealiseAF survey. Indian Heart J. 2016 Sep - Oct; 68(5):663-670.
    View in: PubMed
    Score: 0.005
  43. Elevated concentrations of serum matrix metalloproteinase-2 and -9 and their associations with circulating markers of cardiovascular diseases in chronic arsenic-exposed individuals. Environ Health. 2015 Dec 04; 14:92.
    View in: PubMed
    Score: 0.005
  44. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Res Bull. 2014 Oct; 109:22-31.
    View in: PubMed
    Score: 0.005
  45. Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients. J Neuroimmunol. 2011 Mar; 232(1-2):179-85.
    View in: PubMed
    Score: 0.004
  46. Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. J Neuroimmunol. 2007 Oct; 190(1-2):139-45.
    View in: PubMed
    Score: 0.003
  47. CD80 binding polyproline helical peptide inhibits T cell activation. J Biol Chem. 2005 Mar 18; 280(11):10149-55.
    View in: PubMed
    Score: 0.002
  48. Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent. J Immunol. 2004 Jul 15; 173(2):731-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.